Myeongmun Pharmaceutical, Foreigners Net Sell 13,000 Shares... Stock Price Down 7.75%
Myeongmun Pharmaceutical ranked among the top searched stocks for 2 days within the past month.
As of 1:30 PM on the 22nd, Myeongmun Pharmaceutical is trading at 10,150 KRW, up 7.75% from the previous day. This marks a 64.24% increase compared to November 25. Myeongmun Pharmaceutical is known as a comprehensive pharmaceutical company focusing on prescription drugs.
Today, foreigners have sold a net 13,000 shares of Myeongmun Pharmaceutical, and institutions have sold a net 16,000 shares, according to provisional data. Over the past 5 days, individual investors have bought a net 215,161 shares, while foreigners and institutions have sold a net 111,356 shares and 27,328 shares, respectively.
On December 18, Myeongmun Pharmaceutical became a market topic with the announcement of the release of 'Hoistar tablets with the same ingredient as the oral COVID-19 treatment'...
Hot Picks Today
About 100 Trillion Won at Stake... "Samsung Strike Is an Unprecedented Opportunity" as Prices Surge 20% [Taiwan Chip Column]
- "Heading for 2 Million Won": The Company the Securities Industry Says Not to Doubt [Weekend Money]
- "Envious of Korean Daily Life"...Foreign Tourists Line Up in Central Myeongdong from Early Morning [Reportage]
- "Anyone Who Visited the Room Salon, Come Forward"… Gangnam Police Station Launches Full Staff Investigation After New Scandal
- Did Samsung and SK hynix Rise Too Much?... Foreign Assets Grow Despite Selling [Weekend Money]


※ Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.